Table 3. Proportion of patients meeting MCID of BCTQ between grpoups Table 3. Proportion of patients meeting MCID of BCTQ between grpoups Table 3. Proportion of patients meeting MCID of BCTQ between grpoups Table 3. Proportion of patients meeting MCID of BCTQ between grpoups Table 3. Proportion of patients meeting MCID of BCTQ between grpoups
Short-axis group (n=21) Long-axis group (n=23) p value
n (%) n (%) n (%)
SSS SSS
Week 2 6 (28.6) 5 (21.7) 5 (21.7) 0.601
Month 1 8 (38.1) 5 (21.7) 5 (21.7) 0.235
Month 3 13 (61.9) 10 (43.5) 10 (43.5) 0.222
Month 6 11 (52.4) 12 (52.2) 12 (52.2) 0.989
FSS FSS
Week 2 5 (23.8) 6 (26.1) 6 (26.1) 0.862
Month 1 8 (38.1) 7 (30.4) 7 (30.4) 0.592
Month 3 14 (66.7) 13 (56.5) 13 (56.5) 0.490
Month 6 13 (61.9) 13 (56.5) 13 (56.5) 0.717
MCID=minimal clinically important difference; SSS=Symptom severity scale; FSS=Functional status scale p value from chi-square test MCID=minimal clinically important difference; SSS=Symptom severity scale; FSS=Functional status scale p value from chi-square test MCID=minimal clinically important difference; SSS=Symptom severity scale; FSS=Functional status scale p value from chi-square test MCID=minimal clinically important difference; SSS=Symptom severity scale; FSS=Functional status scale p value from chi-square test MCID=minimal clinically important difference; SSS=Symptom severity scale; FSS=Functional status scale p value from chi-square test